Activation of the main effector caspase-3 in response to PEP005 was reported in melanoma cells at a concentration of 500 nM [37], but the question, where in the pathway the caspase cascade may be blocked in resistant cells has not been raised so far. Here, CASP3 is linked to melanoma.